Home/ Supplements/ Lysine/ SuperLysine+ Liquid Extract

SuperLysine+ Liquid Extract

product on market Liquid Quantum Health Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin C and D3 have strong research evidence supporting immune function and bone health. The proprietary liquid extract has limited documented evidence regarding its specific efficacy. Overall, the profile combines well-studied vitamins with a less evidenced botanical blend.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for SuperLysine+ Liquid Extract
Open Full PDF View on NIH DSLD →
Details

Label Data

0.7 mL
Serving Size
80
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin C
23 mg (26% DV)
5 mcg (25% DV)
Within RDA (0.3× RDA) 608 studies (A:16, B:251)
Proprietary Blend Liquid Extract
700 mg

Other Ingredients

Water Alcohol
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Use 1 dropper in hot or cold water, or in tea, 4-6 times daily.

Warnings & Precautions

Warnings: Keep out of reach of children.

If pregnant or breastfeeding or if you have a medical condition or if taking any medications or other supplements, consult a health professional before use.

People with high blood pressure should also consult a health professional before use. Safety sealed for your protection

Formulation Notes

Immune support

SuperLysine+ with Echinacea & Shiitake extracts

Metadata

Product Details

UPC / SKU0 46985 03102 8
DSLD Entry Date2023-11-22
Product TypeOther Combinations
FormLiquid
DSLD ID299889
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.